Item 2. Management’s Discussion and Analysis
ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL
CONDITION AND RESULTS OF OPERATIONS
The following discussion and analysis of the Company’s financial
condition and results of operations should be read in conjunction with the financial statements and the notes thereto contained elsewhere
in this report.
Cautionary Note Regarding Forward-Looking Statements
All statements other than statements of historical fact included in
this section and elsewhere in this Form 10-Q regarding the Company’s financial position, business strategy and the plans and objectives
of management for future operations, are forward-looking statements. When used in this Form 10-Q, words such as “anticipate,”
“believe,” “estimate,” “expect,” “intend” and similar expressions, as they relate to us
or the Company’s management, identify forward-looking statements. Such forward-looking statements are based on the beliefs of management,
as well as assumptions made by, and information currently available to, the Company’s management. Actual results could differ materially
from those contemplated by the forward-looking statements as a result of certain factors detailed in our filings with the SEC.
Overview
We are a blank check company incorporated on November 3, 2020 as a
Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization
or similar Business Combination with one or more businesses or entities. We intend to effectuate our initial Business Combination using
cash from the proceeds of the Public Offering and the sale of the Private Placement Warrants, our shares, debt or a combination of cash,
equity and debt.
The issuance of additional shares in a Business Combination:
1. may
significantly dilute the equity interest of existing investors, which dilution would increase if the anti-dilution provisions in the
Class B ordinary shares resulted in the issuance of Class A ordinary shares on a greater than one-to-one basis upon conversion of the
Class B ordinary shares;
2. may
subordinate the rights of holders of Class A ordinary shares if preference shares are issued with rights senior to those afforded our
Class A ordinary shares;
3. could
cause a change in control if a substantial number of our Class A ordinary shares are issued, which may affect, among other things, our
ability to use our net operating loss carry forwards, if any, and could result in the resignation or removal of our present officers
and directors;
4. may
have the effect of delaying or preventing a change of control of us by diluting the share ownership or voting rights of a person seeking
to obtain control of us; and
5. may
adversely affect prevailing market prices for our Units, Class A ordinary shares and/or warrants; and may not result in adjustment to
the exercise price of our warrants.
Similarly, if we issue debt or otherwise incur significant debt, it
could result in:
6. default
and foreclosure on our assets if our operating revenues after an initial Business Combination are insufficient to repay our debt obligations;
7. acceleration
of our obligations to repay the indebtedness even if we make all principal and interest payments when due if we breach certain covenants
that require the maintenance of certain financial ratios or reserves without a waiver or renegotiation of that covenant;
8. our
inability to obtain necessary additional financing if the debt contains covenants restricting our ability to obtain such financing while
the debt is outstanding;
19
9. our
inability to pay dividends on our Class A ordinary shares;
10. using
a substantial portion of our cash flow to pay principal and interest on our debt, which will reduce the funds available for dividends
on our Class A ordinary shares if declared, expenses, capital expenditures, acquisitions and other general corporate purposes;
11. limitations
on our flexibility in planning for and reacting to changes in our business and in the industry in which we operate; and
12. increased
vulnerability to adverse changes in general economic, industry and competitive conditions and adverse changes in government regulation;
and limitations on our ability to borrow additional amounts for expenses, capital expenditures, acquisitions, debt service requirements,
execution of our strategy and other purposes and other disadvantages compared to our competitors who have less debt.
As indicated in the accompanying financial statements, as of March
31, 2023, we had approximately $3,000 of cash and negative working capital of approximately $1,989,000. Further, we expect to incur significant
costs in the pursuit of our initial Business Combination and if we cannot complete a Business Combination by, as extended on January 11,
2023, April 14, 2023 (or, if up to nine additional monthly extensions thereafter are approved by the board of directors, the Termination
Date) we could be forced to wind up our operations and liquidate unless we receive an extension approval from our shareholders. We cannot
assure you that our plans to complete our initial Business Combination will be successful.
On January 11, 2023, we held an Extension Meeting to, in part, amend
our amended and restated memorandum and articles of association to extend the date by which we have to consummate a business combination.
In connection with that vote, the holders of 26,068,281 Class A ordinary shares of the Company properly exercised their right to redeem
their shares for an aggregate price of approximately $10.167 per share, for an aggregate redemption amount of approximately $265,050,166.
Results of Operations
For the period from November 3, 2020 (date of inception) to December
31, 2022, our activities consisted of formation and preparation for the public offering and, subsequent to completion of the public offering
on January 14, 2021, identifying and completing a suitable initial Business Combination. As such, we had no operations or significant
operating expenses until after the completion of the Public Offering in January 2021.
Our normal operating costs since January 14, 2021 include costs associated
with our search for an initial Business Combination (see below), costs associated with our governance and public reporting (see below),
and a charge of $25,000 per month from our Sponsor for administrative services. Costs for such Sponsor provided administrative services
aggregate approximately $75,000 for each of the three months ended March 31, 2023 and 2022. Costs associated with our governance and public
reporting have increased since the Public Offering and were approximately $248,000 and $116,000, respectively, for the three months ended
March 31, 2023 and 2022. The increase in the three months ended March 31, 2023 relates to the costs associated with the Extension Meeting
of shareholder held in January 2023. Professional costs associated with the January proxy and Extension Meeting as well as work related
to reviewing potential business combinations was approximately $744,000 in the three months ended March 2023.
During the three months ended March 31, 2023, the Company negotiated
settlement and release agreements with various creditors in exchange for certain payments made and resulting in the reversal of accruals
totaling approximately $2,961,000 which is included as a credit to operating expenses in the accompanying Condensed Statements of Operations.
As we identify and evaluate initial Business Combination candidates,
our costs are expected to increase significantly in connection with investigating potential initial Business Combination candidates, as
well as additional professional, due diligence and consulting fees and travel costs that will be required and professional and other costs
associated with negotiating and executing a definitive agreement and related agreements and related required public reporting and governance
matters.
20
Other income (expense) includes both interest income and the change
in the fair value of the Public and Private Warrants at each reporting date. Interest income was approximately $921,000 and $25,000 respectively,
for the three months ended March 31, 2023 and 2022. The variation in interest income reflect market conditions occurring in connection
with the Covid-19 pandemic and its aftermath. The Company is required to measure the fair value of the Public and Private Warrants at
the end of each reporting period and recognize changes in the fair value from the prior period in the Company’s operating results
for each current period. The change in fair value of warrants was an other expense of approximately $2,020,000 and other income of approximately
$9,029,000, respectively in the three months ended March 31, 2023 and 2022.
There were no income tax expenses for the three months ended March
31, 2023 and 2022 because we are a Cayman Islands exempted company and are not subject to income tax in the United States or in the Cayman
Islands. We did not withdraw any interest from the Trust Account in the three months ended March 31, 2023 or 2022.
Liquidity and Capital Resources
On January 14, 2021, we consummated the Public Offering of an aggregate
of 30,000,000 Units at a price of $10.00 per unit generating gross proceeds of approximately $300,000,000 before underwriting discounts
and expenses. Simultaneously with the consummation of the Public Offering, we consummated the private placement of 5,566,667 Private Placement
Warrants, each exercisable to purchase one share of our Class A ordinary shares at $11.50 per share, to the Sponsor, at a price of $1.50
per Private Placement Warrant, generating gross proceeds, before expenses, of approximately $8,350,000. At that time, the proceeds in
the Trust Account were initially invested in cash. At December 31, 2022 and 2021, the proceeds in the Trust Account are invested in a
money market fund that invests solely U.S. government treasury bills.
The net proceeds from the Public Offering and private placement were
approximately $301,471,000, net of the non-deferred portion of the underwriting commissions of $6,000,000 and offering costs and other
expenses of approximately $904,000 (including approximately $554,000 of offering expenses and approximately $350,000 of insurance that
is accounted for as prepaid expense). $300,000,000 of the proceeds of the Public Offering and the private placement have been deposited
in the Trust Account and are not available to us for operations (except certain amounts to pay taxes, if any). At December 30, 2022 and
2021, we had approximately $3,000 and $101,000, respectively, of cash available outside of the Trust Account to fund our activities until
we consummate an initial Business Combination.
On January 11, 2023, certain shareholders elected to redeem 26,068,281
Class A ordinary shares at $10.167 per share, approximately $265,050,000, from the Trust Account.
Until the consummation of the Public Offering, the Company’s
only sources of liquidity were an initial purchase of our Class B ordinary shares for $25,000 by the Sponsor, and the availability of
loans to us of up to $300,000 by our sponsor under an unsecured promissory note, a total of $199,000 was actually
loaned by the Sponsor against the issuance of the note. The note was non-interest bearing and was paid in full on January 14, 2021 in
connection with the closing of the Public Offering, accordingly, no amounts are available or were outstanding under the Note at March
31, 2023 and 2022.
Mandatory Liquidation and Going Concern:
At March 31, 2023, the Company has approximately $3,000 in cash and
approximately $1,989,000 in negative working capital. The Company has incurred significant costs and expects to continue to incur additional
costs in pursuit of its Business Combination. Further, if the Company cannot complete a Business Combination within the Combination Period,
it could be forced to wind up its operations and liquidate unless it receives an extension approval from its shareholders. These conditions
raise substantial doubt about the Company’s ability to continue as a going concern for a period of time within one year after the
date that the financial statements are issued. In connection with its financial position and intention to complete a business combination,
the Company has secured financing from it Sponsor. The Company’s plan to deal with these uncertainties is to use the financing from
the Sponsor to complete a Business Combination prior to deadline as extended from time to time. There is no assurance that the Company’s
plans to consummate a Business Combination will be successful or successful within the Combination Period. The financial statements do
not include any adjustments that might result from the outcome of this uncertainty.
21
On August 1, 2022, the Company issued a promissory note in the principal amount of up to $2,000,000 to its Sponsor. The note was issued in connection with advances the
Sponsor may make to the Company for expenses reasonably related to its business and the consummation of the Business Combination.
The note bears no interest and was due and payable upon the earlier to occur of (i) January 14, 2023 and (ii) the effective date of
a merger, capital share exchange, asset acquisition, share purchase, reorganization or similar business combination, involving the
Company and one or more businesses (the “Business Combination”). On January 13, 2023, the Company and the Sponsor agreed
to extend the date of maturity of the note to the earlier of (i) the Termination Date of January 14 2024, (ii) the consummation of a
business combination of the Company and (iii) the liquidation of the Company. As of March 31, 2023 and December 31, 2022, the
outstanding principal balance under the note was approximately $755,000 and $785,000.
On January 13, 2023, the Company and the Sponsor agreed to extend the
date of maturity of the note to the earlier of (i) the Termination Date, (ii) the consummation of a business combination of the Company
and (iii) the liquidation of the Company.
On January 3, 2023, the Company issued a promissory note (the “January
3, 2023 Note” or “Extension Promissory Notes – related party”) in the principal amount of up to $250,000 to its
Sponsor. The January 3, 2023 Note was issued in connection with advances the Sponsor may make to the Company for expenses reasonably related
to its business and the consummation of the Business Combination. The January 3, 2023 Note bears no interest and is due and payable upon
the Business Combination. As of March 31, 2023, no amounts have been drawn down and there was no outstanding principal balance under the
note. At the election of the Payee, $250,000 of the unpaid principal amount of the January 3, 2023 Note may be converted into warrants
of the Company (“Warrants”), at a price of $1.50 per warrant, each warrant exercisable for one Class A ordinary share, $0.0001
par value per share, of the Company. The Warrants shall be identical to the Private Placement Warrants issued to the Sponsor at the time
of the Company’s initial public offering.
On January 13, 2023, the Company issued a promissory note (the “January
13, 2023 Note” or “Extension Promissory Notes – related party”) in the principal amount of up to $3,000,000 to
its Sponsor. The January 13, 2023 Note was issued in connection with advances the Sponsor may make to the Company for contributions to
the Trust Account in connection with the Extension and other expenses reasonably related to its business and the consummation of the Business
Combination. The January 13, 2023 Note bears no interest and is due and payable upon the Business Combination. At the election of the
Payee, all or a portion of the unpaid principal amount of the Note may be converted into Warrants, at a price of $1.50 per warrant, each
warrant exercisable for one Class A ordinary share, $0.0001 par value per share, of the Company. The Warrants shall be identical to the
Private Placement Warrants issued to the Sponsor at the time of the Company’s initial public offering.
During the three months ended March 31, 2023, the Company made four
drawdowns under the January 13, 2023 Note in order to pay extension payments and for working capital. At each draw and at March 31, 2023,
the company had an independent valuation firm value the notes. Those valuations showed that the fair value of the notes (approximately
$572,000) was materially less than the drawdown (approximately 377,000 less). The aggregate principal balance outstanding was then revalued
to fair value at March 31, 2023 resulting in an increase to the fair value of approximately $32,000 and is stated in the balance stated
at March 31, 2023 at fair value of $604,000, approximately $345,000 less than the outstanding principal balance under the note of approximately
$949,000.
We expect our principal liquidity requirements during this period to
include legal, accounting, due diligence, travel and other expenses associated with structuring, negotiating and documenting a successful
business combination; legal and accounting fees related to regulatory reporting obligations; payment for investment professionals’
services and support services; Nasdaq continued listing fees; and general working capital that will be used for miscellaneous expenses
and reserves.
Our estimates of expenses may differ materially from our actual expenses.
In addition, we could use a portion of the funds not being placed in trust to pay commitment fees for financing, fees to consultants to
assist us with our search for a target business or as a down payment or to fund a “no-shop” provision (a provision designed
to keep target businesses from “shopping” around for transactions with other companies or investors on terms more favorable
to such target businesses) with respect to a particular proposed business combination, although we do not have any current intention to
do so. If we entered into an agreement where we paid for the right to receive exclusivity from a target business, the amount that would
be used as a down payment or to fund a “no-shop” provision would be determined based on the terms of the specific business
combination and the amount of our available funds at the time. Our forfeiture of such funds (whether as a result of our breach or otherwise)
could result in our not having sufficient funds to continue searching for, or conducting due diligence with respect to, prospective target
businesses.
Moreover, we may need to obtain additional financing to complete our
initial Business Combination, either because the transaction requires more cash than is available from the proceeds held in our Trust
Account, or because we become obligated to redeem a significant number of our public shares upon completion of the Business Combination,
in which case we may issue additional securities or incur debt in connection with such Business Combination. If we have not consummated
our initial Business Combination within the Combination Period because we do not have sufficient funds available to us, we will be forced
to cease operations and liquidate the Trust Account.
The Company has, as extended on January 11, 2023, until April 14, 2023
(or, if up to nine additional monthly extensions thereafter are approved by the board of directors, the Termination Date) to complete
an initial Business Combination (the “initial Business Combination”). If the Company does not complete an initial Business
Combination by the end of the Combination Period, the Company will (i) cease all operations except for the purposes of winding up; (ii)
as promptly as reasonably possible, but not more than ten business days thereafter, redeem the public Class A ordinary shares for a pro
rata portion of the Trust Account, including interest earned on funds held in the Trust Account and not previously released to pay income
taxes, but less up to $100,000 of such interest to pay dissolution expenses and (iii) as promptly as reasonably possible following such
redemption, dissolve and liquidate the balance of the Company’s net assets to its creditors and remaining shareholders, as part
of its plan of dissolution and liquidation. The initial shareholders have waived their redemption rights with respect to their founder
shares; however, if the initial shareholders or any of the Company’s officers, directors or their affiliates acquire Class A ordinary
shares in or after the Public Offering, they will be entitled to a pro rata share of the trust account upon the Company’s redemption
or liquidation in the event the Company does not complete an initial Business Combination within the required time period.
22
In the event of such liquidation, it is possible that the per share
value of the residual assets remaining available for distribution (including Trust Account assets) will be less than the price per unit
in the Public Offering.
Off-balance sheet financing arrangements
We have no obligations, assets or liabilities which would be considered
off-balance sheet arrangements. We do not participate in transactions that create relationships with unconsolidated entities or financial
partnerships, often referred to as variable interest entities, which would have been established for the purpose of facilitating off-balance
sheet arrangements.
We have not entered into any off-balance sheet financing arrangements,
established any special purpose entities, guaranteed any debt or commitments of other entities, or entered into any agreements for non-financial
assets.
Contractual obligations
At March 31, 2022, we did not have any long-term debt, capital lease
obligations, operating lease obligations or long-term liabilities. In connection with the Public Offering, we entered into an Administrative
Support Agreement with the Sponsor, pursuant to which the Company pays the Sponsor $25,000
per month for office space, utilities and secretarial and administrative support.
In connection with identifying an initial Business Combination candidate
and negotiating an initial Business Combination, the Company may enter into engagement letters or agreements with various consultants,
advisors, professionals and others in connection with an initial Business Combination. The services under these engagement letters and
agreements can be material in amount and in some instances can include contingent or success fees. Contingent or success fees (but not
deferred underwriting compensation) would be charged to operations in the quarter that an initial Business Combination is consummated.
In most instances (except with respect to our independent registered public accounting firm), these engagement letters and agreements
are expected to specifically provide that such counterparties waive their rights to seek repayment from the funds in the Trust Account.
JOBS Act
The JOBS Act contains provisions that, among other things, relax certain
reporting requirements for qualifying public companies. We will qualify as an “emerging growth company” and under the JOBS
Act will be allowed to comply with new or revised accounting pronouncements based on the effective date for private (not publicly traded)
companies. We are electing to delay the adoption of new or revised accounting standards, and as a result, we may not comply with new or
revised accounting standards on the relevant dates on which adoption of such standards is required for non-emerging growth companies.
As a result, our financial statements may not be comparable to companies that comply with new or revised accounting pronouncements as
of public company effective dates.
Additionally, we are in the process of evaluating the benefits of
relying on the other reduced reporting requirements provided by the JOBS Act. Subject to certain conditions set forth in the JOBS
Act, if, as an “emerging growth company,” we choose to rely on such exemptions we may not be required to, among other
things, (i) provide an auditor’s attestation report on our system of internal controls over financial reporting pursuant to
Section 404 of the Sarbanes-Oxley Act, (ii) provide all of the compensation disclosure that may be required of non-emerging growth
public companies under the Dodd-Frank Wall Street Reform and Consumer Protection Act, (iii) comply with any requirement that may be
adopted by the PCAOB regarding mandatory audit firm rotation or a supplement to the auditor’s report providing additional
information about the audit and the financial statements (auditor discussion and analysis) and (iv) disclose certain executive
compensation related items such as the correlation between executive compensation and performance and comparisons of the Chief
Executive Officer’s compensation to median employee compensation. These exemptions will apply for a period of five years
following the completion of our Public Offering or until we are no longer an “emerging growth company,” whichever is
earlier.
23
Critical Accounting Estimates
The requirement under 229.303 (Item 303) Management’s
discussion and analysis of financial condition and results of operations is: Critical accounting estimates. Critical accounting estimates
are those estimates made in accordance with generally accepted accounting principles that involve a significant level of estimation uncertainty
and have had or are reasonably likely to have a material impact on the financial condition or results of operations of the registrant.
Provide qualitative and quantitative information necessary to understand the estimation uncertainty and the impact the critical accounting
estimate has had or is reasonably likely to have on financial condition or results of operations to the extent the information is material
and reasonably available. This information should include why each critical accounting estimate is subject to uncertainty and, to the
extent the information is material and reasonably available, how much each estimate and/or assumption has changed over a relevant period,
and the sensitivity of the reported amount to the methods, assumptions and estimates underlying its calculation.
The preparation of financial statements and
related disclosures in conformity with GAAP requires
management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets
and liabilities at the date of the financial statements, and income and expenses during the periods reported.
Actual results could materially differ from
those estimates. Management has determined that the Company has no critical accounting estimates.
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.